The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

A review of JADER and FAERS databases identified common adverse effects for 3 antibody-drug conjugates with the same type of payload.

In just the past 8 years since we launched this report, the 5-year survival rate has gone from 18% to nearly 30%,” said Harold Wimmer, President and CEO of the American Lung Association.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.

Consistently reaching guidelines at moderate levels over three decades associated with significant reduction in digestive cancer risk.